Literature DB >> 17904555

Activation and inhibition of the proteasome by betulinic acid and its derivatives.

Li Huang1, Phong Ho, Chin-Ho Chen.   

Abstract

This study discovered that betulinic acid (BA) is a potent proteasome activator that preferentially activates the chymotrypsin-like activity of the proteasome. Chemical modifications can transform BA into proteasome inhibitors. Chemical modifications at the C-3 position of BA resulted in compounds, such as dimethylsuccinyl BA (DSB), with various inhibitory activities against the human 20S proteasome. Interestingly, the proteasomal activation by BA and the inhibitory activity of DSB could be abrogated by introducing a side chain at the C-28 position. In summary, this study discovered a class of small molecules that can either activate or inhibit human proteasome activity depending on side chain modifications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904555      PMCID: PMC2083647          DOI: 10.1016/j.febslet.2007.09.031

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  30 in total

Review 1.  The proteasome, a novel protease regulated by multiple mechanisms.

Authors:  G N DeMartino; C A Slaughter
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

Review 2.  Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors.

Authors:  Martin Rechsteiner; Christopher P Hill
Journal:  Trends Cell Biol       Date:  2005-01       Impact factor: 20.808

3.  Betulinic acid induces apoptosis in human neuroblastoma cell lines.

Authors:  M L Schmidt; K L Kuzmanoff; L Ling-Indeck; J M Pezzuto
Journal:  Eur J Cancer       Date:  1997-10       Impact factor: 9.162

4.  Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors.

Authors:  S Fulda; C Friesen; M Los; C Scaffidi; W Mier; M Benedict; G Nuñez; P H Krammer; M E Peter; K M Debatin
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

5.  Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors.

Authors:  S Fulda; I Jeremias; T Pietsch; K M Debatin
Journal:  Klin Padiatr       Date:  1999 Jul-Aug       Impact factor: 1.349

6.  Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives.

Authors:  Li Huang; Phong Ho; Kuo-Hsiung Lee; Chin-Ho Chen
Journal:  Bioorg Med Chem       Date:  2005-11-28       Impact factor: 3.641

7.  The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".

Authors:  Huanjie Yang; Guoqing Shi; Q Ping Dou
Journal:  Mol Pharmacol       Date:  2006-11-08       Impact factor: 4.436

8.  Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.

Authors:  Huanjie Yang; Di Chen; Qiuzhi Cindy Cui; Xiao Yuan; Q Ping Dou
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

9.  Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.

Authors:  Sudhakar Chintharlapalli; Sabitha Papineni; Shashi K Ramaiah; Stephen Safe
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

10.  Proteasome activator enhances survival of Huntington's disease neuronal model cells.

Authors:  Hyemyung Seo; Kai-Christian Sonntag; Woori Kim; Elena Cattaneo; Ole Isacson
Journal:  PLoS One       Date:  2007-02-28       Impact factor: 3.240

View more
  30 in total

1.  Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.

Authors:  Corey L Jones; Evert Njomen; Benita Sjögren; Thomas S Dexheimer; Jetze J Tepe
Journal:  ACS Chem Biol       Date:  2017-08-01       Impact factor: 5.100

2.  Synthesis and proteasome inhibition of glycyrrhetinic acid derivatives.

Authors:  Li Huang; Donglei Yu; Phong Ho; Keduo Qian; Kuo-Hsiung Lee; Chin-Ho Chen
Journal:  Bioorg Med Chem       Date:  2008-06-05       Impact factor: 3.641

Review 3.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

Review 4.  Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.

Authors:  Evert Njomen; Jetze J Tepe
Journal:  J Med Chem       Date:  2019-03-14       Impact factor: 7.446

5.  Establishment of a suite of assays that support the discovery of proteasome stimulators.

Authors:  Darci J Trader; Scott Simanski; Paige Dickson; Thomas Kodadek
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-01-05       Impact factor: 3.770

6.  Endoplasmic reticulum-associated degradation controls cell surface expression of γ-aminobutyric acid, type B receptors.

Authors:  Khaled Zemoura; Marisa Schenkel; Mario A Acuña; Gonzalo E Yévenes; Hanns Ulrich Zeilhofer; Dietmar Benke
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

7.  Small molecule screen reveals regulation of survival motor neuron protein abundance by Ras proteins.

Authors:  Reka R Letso; Andras J Bauer; Mitchell R Lunn; Wan Seok Yang; Brent R Stockwell
Journal:  ACS Chem Biol       Date:  2013-03-29       Impact factor: 5.100

Review 8.  Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents.

Authors:  Reen-Yen Kuo; Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2009-08-13       Impact factor: 13.423

Review 9.  Proteasome regulators: activators and inhibitors.

Authors:  Li Huang; Chin Ho Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Synthesis of Lithocholic Acid Derivatives as Proteasome Regulators.

Authors:  Zhao Dang; Kathy Jung; Keduo Qian; Kuo-Hsiung Lee; Li Huang; Chin-Ho Chen
Journal:  ACS Med Chem Lett       Date:  2012-08-15       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.